Optimizing Triheptanoin Therapy

18 min · 14 de nov de 2024

Descripción

* Clinical safety and efficacy * Initiation and titration * Administration considerations * Individualizing treatment

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Bridging Gaps, Optimizing Treatment in Patients With LC-FAODs!

4 episodios

Clinical Case Vignettes

* Initiating triheptanoin * Dosing modification to improve tolerability

Optimizing Triheptanoin Therapy

* Clinical safety and efficacy * Initiation and titration * Administration considerations * Individualizing treatment

Historical Treatment; Introduction of Triheptanoin

* Dietary modification * MCT supplementation * Triheptanoin mechanism of action

Understanding LC-FAODs

* Autosomal recessive inheritance * Carnitine shuttle * Newborn screening * Clinical features